Process for producing pharmaceutical compositions containing 3-etoxycarbonyl-1,6-dimetil-4-oxo-6,7,8,9-tetrahydro-4h-pyrido/1,2-a/pyrimidinium-methosulfate as active component for preventing and treating gastrointestinal damages
Prevention and cure of gastrointestinal damage comprises administering adequate doses to patients of racemic or optically active: 3-ethoxy- carbonyl-1,6-di methyl-4-oxo-6,7,8,9-tetra hydro- 4-H-pyrido- (1,2,-e)-pyrimidiniku metho-sulphate.